Paying users zone. Data is covered by 
.
Get 1 month access to Bristol-Myers Squibb Co. for $17.99, or
get full access to entire website for at least 3 months from $49.99.
We accept:
Bristol-Myers Squibb Co. (BMY)
Analysis of Inventory
Difficulty: Advanced
Inventory Accounting Policy
Inventories are stated at the lower of average cost or market.
Source: 10-K (filing date: 2019-02-25).
Inventory Disclosure
Bristol-Myers Squibb Co., Statement of Financial Position, Inventory
US$ in millions
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Finished goods | |
|
|
|
|
||||||
| Work in process | |
|
|
|
|
||||||
| Raw and packaging materials | |
|
|
|
|
||||||
| Inventories | |
|
|
|
|
Based on: 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13).
| Item | Description | The company |
|---|---|---|
| Inventories | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. | Bristol-Myers Squibb Co.’s inventories increased from 2016 to 2017 and from 2017 to 2018. |